BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poon RT, Fan ST, Wong J. Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches. Ann Surg. 2003;238:9-28. [PMID: 12832961 DOI: 10.1097/01.sla.0000075047.47175.35] [Cited by in Crossref: 36] [Cited by in F6Publishing: 49] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Sultana MF, Abo H, Kawashima H. Human and mouse angiogenins: Emerging insights and potential opportunities. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1022945] [Reference Citation Analysis]
2 Li SQ, Yang Y, Ye LS. Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy. World J Gastroenterol 2022; 28(42): 6034-6044 [DOI: 10.3748/wjg.v28.i42.6034] [Reference Citation Analysis]
3 Chen P, Li Y, Wei P, Liang L, Li B, Cao Y, Han X, Wang Y, Duan X, Jia H, Zhao T, Ren J. siRNA targeting PD-L1 delivered with attenuated Salmonella enhanced the anti-tumor effect of lenvatinib on mice bearing Hepatocellular carcinoma. Int Immunopharmacol 2022;111:109127. [PMID: 35964407 DOI: 10.1016/j.intimp.2022.109127] [Reference Citation Analysis]
4 Ionescu CA, Aschie M, Matei E, Cozaru GC, Deacu M, Mitroi AF, Baltatescu GI, Nicolau AA, Mazilu L, Tuta LA, Iorga IC, Stanigut A, Enciu M. Characterization of the Tumor Microenvironment and the Biological Processes with a Role in Prostatic Tumorigenesis. Biomedicines 2022;10:1672. [PMID: 35884977 DOI: 10.3390/biomedicines10071672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li X, Su X, Yan C, Ma Y, Li H, Xia J, Li H, Jiang Q, Zhou L, Zou Z. Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2022. [PMID: 35767192 DOI: 10.1007/s00432-022-04122-x] [Reference Citation Analysis]
6 Wang Z, Hou Y, Yao Z, Zhan Y, Chen W, Liu Y. Expressivity of Interleukin-8 and Gastric Cancer Prognosis Susceptibility: A Systematic Review and Meta-Analysis. Dose Response 2021;19:15593258211037127. [PMID: 34531708 DOI: 10.1177/15593258211037127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wong JS, Dong Y, Tang V, Leung T, Yeung CSY, Tai A, Law A, Shum T, Kwok GG, Li BC, Leung R, Chiu J, Ma KW, She WH, Tsang J, Cheung TT, Yau T. The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong-A Territory-Wide Cohort Study. Cancers (Basel) 2021;13:2002. [PMID: 33919277 DOI: 10.3390/cancers13092002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Li H. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma. Expert Rev Gastroenterol Hepatol 2021;15:217-33. [PMID: 33131349 DOI: 10.1080/17474124.2021.1842732] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
9 Wang J, Zhang M, Zhou T, Zhao S, Su Z, Liu X. Role of platelet infiltration as independent prognostic marker for gastric adenocarcinomas. J Clin Lab Anal 2020;34:e23320. [PMID: 32233046 DOI: 10.1002/jcla.23320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Okamura S, Osaki T, Nishimura K, Ohsaki H, Shintani M, Matsuoka H, Maeda K, Shiogama K, Itoh T, Kamoshida S. Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels. Biotechnic & Histochemistry 2018;94:60-4. [DOI: 10.1080/10520295.2018.1499962] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
11 Fang S, Hong H, Li L, He D, Xu Z, Zuo S, Han J, Wu Q, Dai Z, Cai W, Ma J, Shao C, Gao G, Yang X. Plasminogen kringle 5 suppresses gastric cancer via regulating HIF-1α and GRP78. Cell Death Dis 2017;8:e3144. [PMID: 29072683 DOI: 10.1038/cddis.2017.528] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
12 Lin J, Lin Y, Su L, Su Q, Guo W, Huang X, Wang C, Lin L. The role of Jagged1/Notch pathway-mediated angiogenesis of hepatocarcinoma cells in vitro, and the effects of the spleen-invigorating and blood stasis-removing recipe. Oncol Lett 2017;14:3616-22. [PMID: 28927121 DOI: 10.3892/ol.2017.6611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Chen G, Li X, Yang J, Li J, Wang X, He J, Huang Z. Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysis. Arch Med Sci. 2016;12:1110-1117. [PMID: 27695503 DOI: 10.5114/aoms.2016.61916] [Cited by in Crossref: 17] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
14 Xia W, Chen W, Zhang Z, Wu D, Wu P, Chen Z, Li C, Huang J. Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis. PLoS One 2015;10:e0123484. [PMID: 25856316 DOI: 10.1371/journal.pone.0123484] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
15 Bolondi L, Gramantieri L. From liver cirrhosis to HCC. Intern Emerg Med 2011;6 Suppl 1:93-8. [PMID: 22009618 DOI: 10.1007/s11739-011-0682-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
16 Al-Moundhri MS, Al-Hadabi I, Al-Mawaly K, Kumar S, Al-Lawati FA, Bhatnager G, Kuruvila S, Al-Hamdani A, El-Sayed SM, Al-Bahrani B. Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer. Med Oncol. 2012;29:1739-1747. [PMID: 22048943 DOI: 10.1007/s12032-011-0098-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tonino P, Abreu C. Microvessel Density Is Associated with VEGF and α-SMA Expression in Different Regions of Human Gastrointestinal Carcinomas. Cancers (Basel) 2011;3:3405-18. [PMID: 24212960 DOI: 10.3390/cancers3033405] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
18 Martins SF, Reis RM, Rodrigues AM, Baltazar F, Filho AL. Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies. World J Clin Oncol 2011; 2(6): 272-280 [PMID: 21773077 DOI: 10.5306/wjco.v2.i6.272] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
19 Kaseb AO, Hassan MM, Lin E, Xiao L, Kumar V, Pathak P, Lozano R, Rashid A, Abbruzzese JL, Morris JS. V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials. Cancer. 2011;117:2478-2488. [PMID: 24048796 DOI: 10.1002/cncr.25791] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
20 Cavazzola LT, Rosa AR, Schirmer CC, Gurski RR, Telles JP, Mielke F, Meurer L, Edelweiss MI, Kruel CD. Immunohistochemical evaluation for P53 and VEGF (Vascular Endothelial Growth Factor) is not prognostic for long term survival in end stage esophageal adenocarcinoma. Rev Col Bras Cir. 2009;36:24-34. [PMID: 20076865 DOI: 10.1590/S0100-69912009000100007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
21 Huynh H. Molecularly targeted therapy in hepatocellular carcinoma. Biochem Pharmacol. 2010;80:550-560. [PMID: 20371362 DOI: 10.1016/j.bcp.2010.03.034] [Cited by in Crossref: 85] [Cited by in F6Publishing: 98] [Article Influence: 7.1] [Reference Citation Analysis]
22 Takala H, Saarnio J, Wiik H, Ohtonen P, Soini Y. HIF-1α and VEGF are associated with disease progression in esophageal carcinoma. J Surg Res. 2011;167:41-48. [PMID: 20451923 DOI: 10.1016/j.jss.2009.11.725] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
23 Cheng P, Jiang FH, Zhao LM, Dai Q, Yang WY, Zhu LM, Wang BJ, Xu C, Bao YJ, Zhang YJ. Human macrophage metalloelastase correlates with angiogenesis and prognosis of gastric carcinoma. Dig Dis Sci 2010;55:3138-46. [PMID: 20127415 DOI: 10.1007/s10620-010-1127-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
24 Cheng P, Jiang FH, Zhao LM, Dai Q, Yang WY, Zhu LM, Wang BJ, Xu C, Bao YJ, Zhang YJ. Human macrophage metalloelastase correlates with angiogenesis and prognosis of gastric carcinoma. Dig Dis Sci. 2010;55:3138-3146. [PMID: 20127415 DOI: 10.1007/s10620-010-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Vidal O, Metges JP, Elizalde I, Valentíni M, Volant A, Molina R, Castells A, Pera M. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer. Br J Surg 2009;96:1443-51. [PMID: 19918848 DOI: 10.1002/bjs.6780] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
26 Wada H, Nagano H, Yamamoto H, Noda T, Murakami M, Kobayashi S, Marubashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M. Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells. BMC Cancer 2009;9:361. [PMID: 19821965 DOI: 10.1186/1471-2407-9-361] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
27 Kirk MJ, Hayward RM, Sproull M, Scott T, Smith S, Cooley-Zgela T, Crouse NS, Citrin DE, Camphausen K. Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens. J Cell Mol Med 2008;12:1250-5. [PMID: 18782189 DOI: 10.1111/j.1582-4934.2008.00182.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
28 Meteoglu I, Meydan N, Erkus M. Id-1: regulator of EGFR and VEGF and potential target for colorectal cancer therapy. J Exp Clin Cancer Res 2008;27:69. [PMID: 19014499 DOI: 10.1186/1756-9966-27-69] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
29 Höpfner M, Schuppan D, Scherübl H. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. World J Gastroenterol 2008; 14(1): 1-14 [PMID: 18176955 DOI: 10.3748/wjg.14.1] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 88] [Article Influence: 5.2] [Reference Citation Analysis]
30 Bangoura G, Liu ZS, Qian Q, Jiang CQ, Yang GF, Jing S. Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol 2007; 13(23): 3176-3182 [PMID: 17589895 DOI: 10.3748/wjg.v13.i23.3176] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 88] [Article Influence: 5.5] [Reference Citation Analysis]
31 Atkin GK, Chopada A. Tumour angiogenesis: the relevance to surgeons. Ann R Coll Surg Engl 2006;88:525-9. [PMID: 17059709 DOI: 10.1308/003588406X117106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
32 Nie F, Xu HX, Tang Q, Lu MD. Microbubble-enhanced ultrasound exposure improves gene transfer in vascular endothelial cells. World J Gastroenterol 2006; 12(46): 7508-7513 [PMID: 17167842 DOI: 10.3748/wjg.v12.i46.7508] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
33 Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 2006;94:1823-32. [PMID: 16773076 DOI: 10.1038/sj.bjc.6603176] [Cited by in Crossref: 255] [Cited by in F6Publishing: 277] [Article Influence: 15.9] [Reference Citation Analysis]
34 Gospodarowicz MK, O'sullivan B, Koh E. Prognostic Factors: Principles and Applications. In: Sobin LH, editor. TNM Online. Wiley; 2003. [DOI: 10.1002/0471463736.tnmp02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Pang R, Poon RT. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett. 2006;242:151-167. [PMID: 16564617 DOI: 10.1016/j.canlet.2006.01.008] [Cited by in Crossref: 148] [Cited by in F6Publishing: 163] [Article Influence: 9.3] [Reference Citation Analysis]
36 Chi-Man Tang T, Tung-Ping Poon R, Fan ST. The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma. Biomed Pharmacother. 2005;59 Suppl 2:S311-S316. [PMID: 16507400 DOI: 10.1016/S0753-3322(05)80053-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
37 Nikfarjam M, Muralidharan V, Christophi C. Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery. 2006;139:73-81. [PMID: 16364720 DOI: 10.1016/j.surg.2005.07.030] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
38 Mross K, Drevs J, Müller M, Medinger M, Marmé D, Hennig J, Morgan B, Lebwohl D, Masson E, Ho YY, Günther C, Laurent D, Unger C. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. Eur J Cancer 2005;41:1291-9. [PMID: 15939265 DOI: 10.1016/j.ejca.2005.03.005] [Cited by in Crossref: 137] [Cited by in F6Publishing: 140] [Article Influence: 8.1] [Reference Citation Analysis]
39 Bekaii-Saab TS, Villalona-Calero MA. Preclinical experience with docetaxel in gastrointestinal cancers. Semin Oncol 2005;32:S3-9. [PMID: 16015550 DOI: 10.1053/j.seminoncol.2005.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
40 Tang TC, Poon RT, Lau CP, Xie D, Fan ST. Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J Gastroenterol 2005; 11(13): 1896-1902 [PMID: 15800977 DOI: 10.3748/wjg.v11.i13.1896] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 66] [Article Influence: 3.6] [Reference Citation Analysis]
41 Poon RT, Ho JW, Tong CS, Lau C, Ng IO, Fan ST. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br J Surg. 2004;91:1354-1360. [PMID: 15376182 DOI: 10.1002/bjs.4594] [Cited by in Crossref: 164] [Cited by in F6Publishing: 183] [Article Influence: 9.1] [Reference Citation Analysis]
42 Stein HJ, Möbius C. Angiogenesis and neoplastic transformation of Barrett's epithelium. British Journal of Surgery 2004;91:941-2. [DOI: 10.1002/bjs.4633] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
43 Ho JW, Poon RT, Tong CS, Fan ST. Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(14): 2014-2018 [PMID: 15237425 DOI: 10.3748/wjg.v10.i14.2014] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
44 Song ZY, Wen SQ, Peng JP, Huang X, Qian KD. Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer. World J Gastroenterol 2004; 10(9): 1250-1255 [PMID: 15112337 DOI: 10.3748/wjg.v10.i9.1250] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]